myoinositol and sexual functio

Phase 3

Recruiting

• Conditions: Polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20160524028038N17
• Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

age 18 to 40 years
Confirmation of polycystic ovary syndrome based on the Rotterdam criteria
Iranian
Absence of severe mental conditions since six months before the research
Not suffering from severe depression and anxiety according to the depression and anxiety questionnaire
No current use of psychiatric medications
No language or cognitive problems preventing the patient from completing the questionnaire
No smoking
No current use of drugs affecting sexual function
Failure to previously diagnose an organic cause for sexual dysfunction by an experienced physician
Currently taking cyproterone compound tablets as prescribed by the gynecologist

Exclusion Criteria

Patients who do not want to cooperate.
Pregnancy during study

Study & Design

• Study Type: interventional
• Study Design: Not specified